Betta Pharmaceuticals Co. Ltd Financials

Market Capitalization CN¥24.39 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	59.77
Forward PE	34.51
Price to Sales TTM	CN¥7.94
Price to Book MRQ	CN¥4.38
Enterprise to Revenue	8.50
Enterprise to EBITDA	27.50

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	13.16%
Operating Margin	22.85%
Return on Assets TTM	3.82%
Return on Equity TTM	6.91%

Income Statement

Revenue TTM	CN¥3,073,729,024
Revenue per Share TTM	CN¥7.37
Quarterly Revenue Growth	24.70%
Gross Profit TTM	CN¥2,491,951,616
EBITDA	CN¥593,569,488
Net Income to Common TTM	CN¥404,517,792
Diluted EPS TTM	CN¥0.97
Quarterly Earnings Growth YoY	2.00%

Balance Sheet

Total Cash MRQ	CN¥597,767,104
Total Cash per Share MRQ	CN¥1.43
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	42.40
Current Ratio MRQ	0.62
Book Value per Share MRQ	CN¥13.25

Cash Flow

Operating Cash Flow TTM	CN¥961,472,256
Levered Free Cash Flow TTM	CN¥-167,106,592

300558 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	418,485,885
Float Shares	230,568,983
Avg 10 Volume	12,942,238
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	46.17%
% Held by Institutions	14.76%

Stock Price Summary

Beta	0.54
Fifty Two Week Low	CN¥30.43
Fifty Two Week High	CN¥66.50
Fifty Two Week Change	45.65%
Day 50 MA	CN¥55.00
Day 200 MA	CN¥52.00

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.80
Forward Annual Dividend Yield	1.37%
Trailing Annual Dividend Rate	CN¥0.20
Trailing Annual Dividend Yield	0.34%
Payout Ratio	17.53%
Dividend Date
Ex Dividend Date	2025-06-17
Last Split Factor
Last Split Date